Skip to main content

Advertisement

SpringerLink
Log in

2016 FDA drug approvals

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

FDA approval count fell last year, despite a steady regulatory filing rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Novel FDA approvals since 1993.
Figure 2: Potential blockbusters approved by the FDA in 2016.
Figure 3
Authors
  1. Asher Mullard
    View author publications

    You can also search for this author in PubMed Google Scholar

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mullard, A. 2016 FDA drug approvals. Nat Rev Drug Discov 16, 73–76 (2017). https://doi.org/10.1038/nrd.2017.14

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2017.14

  • Springer Nature Limited

This article is cited by

Search

Navigation